English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Thermoplastic polyurethane-based intravaginal rings for prophylaxis and treatment of (recurrent) bacterial vaginosis

Verstraete, G., Vandenbussche, L., Kasmi, S., Nuhn, L., Brouckaert, D., Renterghem, J. V., et al. (2017). Thermoplastic polyurethane-based intravaginal rings for prophylaxis and treatment of (recurrent) bacterial vaginosis. International Journal of Pharmaceutics, 529(1-2), 218-226. doi:10.1016/j.ijpharm.2017.06.076.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Verstraete, G., Author
Vandenbussche, L., Author
Kasmi, S., Author
Nuhn, Lutz1, Author           
Brouckaert, D., Author
Renterghem, J. Van, Author
Grymonpré, W., Author
Vanhoorne, V., Author
Coenye, T., Author
Geest, B.G. De, Author
Beer, T. De, Author
Remon, J.P., Author
Vervaet, C., Author
Affiliations:
1Univ Ghent, Canc Res Inst Ghent, Ghent, Belgium, ou_persistent22              

Content

show
hide
Free keywords: Hot melt extrusion, Intravaginal rings, Bacterial vaginosis, Thermoplastic polyurethanes, Lactic acid, Metronidazole
 Abstract: The aim of the present study was to develop thermoplastic polyurethane (TPU)-based intravaginal rings (IVRs) for prophylaxis and treatment of bacterial vaginosis via hot melt extrusion/injection molding. Therefore, different TPU grades were processed in combination with lactic acid or metronidazole, targeting a sustained lactic acid release over a 28day-period and sustained metronidazole release over 4–7days. Hot melt extrusion of lactic acid/TPU combinations required a lower extrusion temperature due to the plasticizing properties of lactic acid, evidenced by the lower glass transition temperature (Tg) and cross-over point (Ttanδ=1) values. NIR-chemical imaging data showed a homogenous distribution of lactic acid in TPU matrices at drug loads up to 30 (w/w). The addition of metronidazole did not lower processing temperatures, as the active pharmaceutical ingredient remained crystalline in the TPU matrix. Hydrophobic TPUs with a low ratio between the soft and hard segments (SS/HS ratio) in the polymer structure were suitable carriers for the lactic acid-eluting device over a 28-day period, while hydrophilic TPUs were needed to achieve the required release rate of metronidazole-eluting IVRs. IVRs manufactured with a TPU grade having a higher SS/HS ratio and lactic acid/TPU ratio exhibited a more elastic behavior. The addition of 25 (w/w) metronidazole did not affect the mechanical properties of the IVRs. Hydrophilic TPUs were most prone to biofilm formation by Candida albicans and Staphylococcus aureus, but the incorporation of metronidazole in the device prevented biofilm formation. Based on the drug eluting performance and mechanical tests, a mixture of lactic acid and Tecoflex™ EG-93A (20/80, w/w) and a combination of metronidazole and Tecophilic™ SP-93A-100 (25/75, w/w) were selected to design IVRs for the prophylaxis and treatment of bacterial vaginosis, respectively. Slug mucosal irritation tests predicted low irritation potency for both devices.

Details

show
hide
Language(s): eng - English
 Dates: 2017
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.1016/j.ijpharm.2017.06.076
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: International Journal of Pharmaceutics
  Other : Int. J. Pharm.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Amsterdam : Elsevier
Pages: - Volume / Issue: 529 (1-2) Sequence Number: - Start / End Page: 218 - 226 Identifier: ISSN: 0378-5173
CoNE: https://pure.mpg.de/cone/journals/resource/954925527842